HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Stepping Up Pricing To Offset Rising Costs While New Businesses Continue To Fuel Growth

Executive Summary

“We are still managing in COVID times,” says CEO Alan Jope during Unilever’s 22 July call to discuss fiscal 2021 first-half results.

You may also be interested in...



Unilever Q3 Reflects Earth-Friendly Innovation, ‘Thoughtful’ Pricing As Macro Conditions Worsen

Unilever plc dialed up prices almost 4% in the third quarter in its Beauty and Personal Care division, more than offsetting volume decline to achieve 2.6% underlying sales growth to €5.7bn. Outstanding brand innovations include refillable deodorants and eyeshadow palettes and biodegradable shampoo.  

Unilever Invites Pitches From Social Commerce Startups, Chasing ‘Mega-Trends Of The Future’

Firm extends invitation to startups in livestream commerce, shoppable media, group buying, and gaming commerce to submit for the chance to pitch to Unilever beauty brands as part of the company’s Positive Beauty Growth Platform.

Unilever To Fuel Skin Care, E-Commerce Engines With Paula’s Choice Acquisition

Paula’s Choice ticks skin-care and e-commerce boxes at a time of increased wellness and home shopping demand. The balance it strikes between acknowledging consumer ingredient preferences and upholding scientific method may also be part of the brand's appeal.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel